What is the market cap of Bcworldpharm?

The market capitalisation of Bcworldpharm was ₩30B at the close on Oct 30, 2026.

Who are the largest shareholders of Bcworldpharm?

According to the latest official filings, the largest reported holders are Hong Seong-han (38.53%, as of Aug 4, 2026); Hong Yeong-gi (12.55%, as of Apr 1, 2026); National Pension Service (0.20%, as of Dec 31, 2018).

When is the next earnings report from Bcworldpharm?

Korean companies rarely announce results dates in advance. Based on when Bcworldpharm filed the same report in past years, its next 3q results is expected between Nov 13, 2026 and Nov 14, 2026.

Does the National Pension Service own Bcworldpharm?

Yes. The National Pension Service held 0.20% of Bcworldpharm shares as of Dec 31, 2018.

KOSDAQ · 200780 · Biotech & Pharma · ₩200780

Bcworldpharm비씨월드제약

200780 · KOSDAQ · ₩200780 · 비씨월드제약

₩2,790▼ ₩30 (1.06%)End-of-day · Oct 30, 2026 · End-of-day prices.

Trade

Price · 1Y −33.56%

Market cap: ₩30B
Enterprise value: ₩113B
P/E: —
P/B: 0.4×
Dividend yield: 3.6%
ROE: −4.2%
Net margin: −3.6%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−53.7% from the high

₩2,730Today: ₩2,750 – ₩2,910₩6,030

Returns

1W−2.1%
1M−7.5%
3M−9.7%
6M−37.2%
YTD−49.4%
1Y−33.6%

Volume today: 3,959; 0.5× the 20-day average
Traded today: ₩11M
Listed shares: 10,665,661
EPS (12 months): −₩272; Earnings yield −9.7%

Sell Buy

AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Nov 13Earnings Expected · 3Q results

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

X f WA TG r/in @

Signals

Quiet

BuzzQuietBuzz 35 of 100 (50 is a normal day for this stock).
MomentumWeak-7% over the last month; the price is below its 20-day average.
News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.

Signals describe activity, not recommendations. Not financial advice.

Bcworldpharm stock overview

Bcworldpharm (비씨월드제약, KRX: 200780) is listed on KOSDAQ, in the Biotech & Pharma sector. The company manufactures and sells prescription pharmaceuticals, with a focus on R&D-driven new drugs and improved formulations using its proprietary drug delivery system (DDS) technology. Its shares closed at ₩2,790 on Oct 30, 2026, down 1.06% on the day, giving it a market value of ₩30B.

Market cap: ₩30B
Sector: Biotech & Pharma
Latest price change: −1.06%
As of: Oct 30, 2026
Main business: The company manufactures and sells prescription pharmaceuticals, with a focus on R&D-driven new drugs and improved formulations using its proprietary drug delivery system (DDS) technology.

Quick answers about Bcworldpharm

What does Bcworldpharm do?: The company manufactures and sells prescription pharmaceuticals, with a focus on R&D-driven new drugs and improved formulations using its proprietary drug delivery system (DDS) technology. Its main product areas include anesthetic and pain medications, antibiotics and other prescription drugs, which it sells domestically and exports to Europe, Latin America, the Middle East, CIS countries and Asia. It also provides contract manufacturing and development services (CMO/CDMO) to other Korean pharmaceutical companies and licenses its R&D technology to overseas partners.
What is the market cap of Bcworldpharm?: The market capitalisation of Bcworldpharm was ₩30B at the close on Oct 30, 2026.
Who are the largest shareholders of Bcworldpharm?: According to the latest official filings, the largest reported holders are Hong Seong-han (38.53%, as of Aug 4, 2026); Hong Yeong-gi (12.55%, as of Apr 1, 2026); National Pension Service (0.20%, as of Dec 31, 2018).
When is the next earnings report from Bcworldpharm?: Korean companies rarely announce results dates in advance. Based on when Bcworldpharm filed the same report in past years, its next 3q results is expected between Nov 13, 2026 and Nov 14, 2026.
Does the National Pension Service own Bcworldpharm?: Yes. The National Pension Service held 0.20% of Bcworldpharm shares as of Dec 31, 2018.

Company profile

The company manufactures and sells prescription pharmaceuticals, with a focus on R&D-driven new drugs and improved formulations using its proprietary drug delivery system (DDS) technology. Its main product areas include anesthetic and pain medications, antibiotics and other prescription drugs, which it sells domestically and exports to Europe, Latin America, the Middle East, CIS countries and Asia. It also provides contract manufacturing and development services (CMO/CDMO) to other Korean pharmaceutical companies and licenses its R&D technology to overseas partners. Its consolidated group includes a pharmaceutical manufacturing subsidiary and an advertising agency subsidiary.

Written by AI from the company's latest annual report.

Korean name: 비씨월드제약
Sector: Biotech & Pharma
Themes: Pharmaceuticals
CEO: 홍성한
Founded: Mar 1980
Listed: Dec 2014
Listed shares: 10,665,661
Fiscal year ends: Month 12
Website: www.bcwp.co.kr

Similar companies

Samsung Biologics207940 · ₩69T₩1,487,000+8.86%
Celltrion068270 · ₩44T₩191,600+1.22%
Alteogen196170 · ₩15T₩211,500−3.86%
SK biopharmaceuticals326030 · ₩6.1T₩77,700−0.13%
Yuhan000100 · ₩5.5T₩75,100+0.54%
HLB028300 · ₩5.3T₩40,000+0.76%
Hanmi Pharm128940 · ₩5.3T₩415,000+6.82%
SAM Chun Dang Pharm000250 · ₩4.3T₩182,700−3.13%

Recent filings

See all

Titles in Korean until English translations are added.

Key numbers

Volume: 3,959
Traded value: ₩11M
Day range: ₩2,750 – ₩2,910
Revenue (TTM): ₩80B
Operating margin: 3.5%
Net margin: −3.6%
ROE: −4.2%
Revenue growth (last year): +1.3%
Liabilities to equity: 143%
Foreign ownership: 1.23%
Short balance: 0.00%

Trailing 12 months from filed financial statements, as of H1 2026.

Who owns Bcworldpharm?

Hong Seong-han홍성한CEO · 사실상지배주주5% reportInsider report38.53%4.1M sharesas of Aug 4, 2026
Hong Yeong-gi홍영기Executive vice president · 10%이상주주Insider report12.55%1.3M sharesas of Apr 1, 2026
National Pension Service국민연금공단NPS year-end0.20%as of Dec 31, 2018
Jang Tae-eok장태억Executive vice presidentInsider report0.16%16.6K sharesas of Apr 1, 2026

From official filings only: 5% reports and executives' and major shareholders' reports (Korea), and US funds' Form N-PORT and US managers' Form 13F (ADRs) reports. Each holder shows its latest report and the date it was as of; the same holder in two reports is shown once.

National Pension Service

0.20% of shares

Year-end 2018 holding

Worth ₩300M

NPS year-end holdings, published annually.

Also known as: Bcworldpharm / 비씨월드제약 / 200780 / KRX:200780

Source: KRX statistical information